Literature DB >> 12164878

Influence of smoking and obesity on the development of proteinuria.

Masahiko Tozawa1, Kunitoshi Iseki, Chiho Iseki, Saori Oshiro, Yoshiharu Ikemiya, Shuichi Takishita.   

Abstract

BACKGROUND: Proteinuria is a significant risk factor for end-stage renal disease. Previous evidence suggested that smoking and obesity increase the risk of proteinuria. However, it is unclear whether these risk factors predict the development of proteinuria independently of hypertension and diabetes mellitus. The aim of this study was to analyze the effects of obesity and smoking on the development of proteinuria in a screened cohort of subjects with normal kidney function.
METHODS: A total of 5403 subjects (3403 men and 2000 women) who participated in the 1997 and 1999 health screening examinations in Okinawa Japan, and who were normal renal function (serum creatinine < or =1.2 mg/dL in men, < or =1.0 mg/dL in women) and negative proteinuria by dipstick examination in 1997 were eligible for study. Logistic analysis was used to examine the relation between the baseline state of smoking or obesity in 1997, and the development of proteinuria in 1999, adjusted for age, sex, and other confounding factors.
RESULTS: Proteinuria developed in 5.8% of participants (6.7% in men, 4.4% in women; dipstick score, 1+ in 277, 2+ in 37, and > or =3+ in 4 participants). The incidence of proteinuria was positively associated with the number of cigarettes smoked per day (P = 0.04), and a body mass index (P < 0.0001) at baseline. Analysis showed that the relative risk (95% confidence interval) of developing proteinuria was 1.32 (1.00 to 1.74), P = 0.04 for cigarette smoking, 1.45 (1.13 to 1.86), P = 0.002 for obesity, 1.56 (1.19 to 2.06), P = 0.001 for hypertension, and 2.27 (1.55 to 3.32), P < 0.0001 for diabetes mellitus. Stratified with men and women, the relative risk was 1.28 (0.96 to 1.72), P = 0.09 for smoking, and 1.60 (1.19 to 2.14), P = 0.001 for obesity in men; the relative risk was 1.30 (0.44 to 3.80), P = 0.62 for smoking, and 1.04 (0.63 to 1.72), P = 0.87 for obesity in women.
CONCLUSIONS: Hypertension and diabetes mellitus were superior to smoking and obesity in predicting the development of proteinuria in all subjects. Stratified with men and women, obesity was a significant risk factor for the development of proteinuria independently of both hypertension and diabetes mellitus in men. The risk of developing proteinuria also tended to be increased with cigarette smoking in men. Smoking and obesity in women were not significant in this data set.

Entities:  

Mesh:

Year:  2002        PMID: 12164878     DOI: 10.1046/j.1523-1755.2002.00506.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  57 in total

1.  Evidence-based practice guideline for the treatment of CKD.

Authors: 
Journal:  Clin Exp Nephrol       Date:  2009-12       Impact factor: 2.801

2.  U-shaped association between body mass index and proteinuria in a large Japanese general population sample.

Authors:  Yuji Sato; Shouichi Fujimoto; Tsuneo Konta; Kunitoshi Iseki; Toshiki Moriyama; Kunihiro Yamagata; Kazuhiko Tsuruya; Hideaki Yoshida; Koichi Asahi; Issei Kurahashi; Yasuo Ohashi; Tsuyoshi Watanabe
Journal:  Clin Exp Nephrol       Date:  2013-05-08       Impact factor: 2.801

3.  Cigarette smoking and the association with glomerular hyperfiltration and proteinuria in healthy middle-aged men.

Authors:  Isseki Maeda; Tomoshige Hayashi; Kyoko Kogawa Sato; Hideo Koh; Nobuko Harita; Yoshiko Nakamura; Ginji Endo; Hiroshi Kambe; Kanji Fukuda
Journal:  Clin J Am Soc Nephrol       Date:  2011-09-01       Impact factor: 8.237

Review 4.  Obesity and renovascular disease.

Authors:  Xin Zhang; Lilach O Lerman
Journal:  Am J Physiol Renal Physiol       Date:  2015-06-03

5.  Different association of cigarette smoking with GFR estimated from serum creatinine and that from serum cystatin C in the general population.

Authors:  Yuichi Yamada; Yuka Noborisaka; Masao Ishizaki; Michiko Yamazaki; Ryumon Honda; Hitoshi Yokoyama; Tatsuyuki Kakuma
Journal:  Clin Exp Nephrol       Date:  2014-11-19       Impact factor: 2.801

6.  Managing cardiovascular risk in people with chronic kidney disease: a review of the evidence from randomized controlled trials.

Authors:  Min Jun; Jicheng Lv; Vlado Perkovic; Meg J Jardine
Journal:  Ther Adv Chronic Dis       Date:  2011-07       Impact factor: 5.091

7.  The effects of continuing and discontinuing smoking on the development of chronic kidney disease (CKD) in the healthy middle-aged working population in Japan.

Authors:  Yuka Noborisaka; Masao Ishizaki; Yuichi Yamada; Ryumon Honda; Hitoshi Yokoyama; Masaru Miyao; Masaji Tabata
Journal:  Environ Health Prev Med       Date:  2012-05-24       Impact factor: 3.674

8.  Heart rate as a risk factor for developing chronic kidney disease: longitudinal analysis of a screened cohort.

Authors:  Taku Inoue; Kunitoshi Iseki; Chiho Iseki; Yusuke Ohya; Kozen Kinjo; Shuichi Takishita
Journal:  Clin Exp Nephrol       Date:  2009-05-15       Impact factor: 2.801

9.  Being overweight modifies the association between cardiovascular risk factors and microalbuminuria in adolescents.

Authors:  Stephanie Nguyen; Charles McCulloch; Paul Brakeman; Anthony Portale; Chi-yuan Hsu
Journal:  Pediatrics       Date:  2008-01       Impact factor: 7.124

10.  Proteinuria and decreased body mass index as a significant risk factor in developing end-stage renal disease.

Authors:  Kunitoshi Iseki; Kaori Tokashiki; Chiho Iseki; Kentaro Kohagura; Kozen Kinjo; Shuichi Takishita
Journal:  Clin Exp Nephrol       Date:  2008-06-27       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.